Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1996 3
1997 1
1998 3
1999 1
2000 3
2001 2
2002 3
2003 1
2004 1
2005 2
2006 4
2007 3
2008 1
2009 2
2010 4
2011 3
2012 4
2013 6
2014 7
2015 8
2016 6
2017 3
2018 3
2019 2
2020 5
2021 3
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, Müller L, Link H, Moehler M, Kettner E, Fritz E, Hieber U, Lindemann HW, Grunewald M, Kremers S, Constantin C, Hipp M, Hartung G, Gencer D, Kienle P, Burkholder I, Hochhaus A. Hofheinz RD, et al. Among authors: matzdorff a. Lancet Oncol. 2012 Jun;13(6):579-88. doi: 10.1016/S1470-2045(12)70116-X. Epub 2012 Apr 13. Lancet Oncol. 2012. PMID: 22503032 Clinical Trial.
The EHA Research Roadmap: Platelet Disorders.
Balduini C, Freson K, Greinacher A, Gresele P, Kühne T, Scully M, Bakchoul T, Coppo P, Dovc Drnovsek T, Godeau B, Gruel Y, Rao AK, Kremer Hovinga JA, Makris M, Matzdorff A, Mumford A, Pecci A, Raslova H, Rivera J, Roberts I, Scharf RE, Semple JW, Van Geet C. Balduini C, et al. Among authors: matzdorff a. Hemasphere. 2021 Jun 30;5(7):e601. doi: 10.1097/HS9.0000000000000601. eCollection 2021 Jul. Hemasphere. 2021. PMID: 34476343 Free PMC article. No abstract available.
Unanswered Questions.
Matzdorff A. Matzdorff A. Dtsch Arztebl Int. 2020 Mar 27;117(13):222. doi: 10.3238/arztebl.2020.0222a. Dtsch Arztebl Int. 2020. PMID: 32343663 Free PMC article. No abstract available.
[Diagnosis and Therapy of Immune thrombocytopenia].
Matzdorff A, Wörmann B. Matzdorff A, et al. Dtsch Med Wochenschr. 2018 Aug;143(15):1076-1081. doi: 10.1055/a-0384-4703. Epub 2018 Jul 30. Dtsch Med Wochenschr. 2018. PMID: 30060276 Review. German.
[Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie].
Matzdorff A, Alesci SR, Gebhart J, Holzhauer S, Hütter-Krönke ML, Kühne T, Meyer O, Ostermann H, Pabinger I, Rummel M, Sachs UJ, Stauch T, Trautmann-Grill K, Wörmann B. Matzdorff A, et al. Oncol Res Treat. 2023;46 Suppl 1:7-53. doi: 10.1159/000528819. Epub 2022 Dec 26. Oncol Res Treat. 2023. PMID: 36572012 Free article. Review. German. No abstract available.
[Immune thrombocytopenia].
Matzdorff A. Matzdorff A. Dtsch Med Wochenschr. 2011 Jun;136(22):1172-4. doi: 10.1055/s-0031-1280533. Epub 2011 May 24. Dtsch Med Wochenschr. 2011. PMID: 21611922 German. No abstract available.
Drug-induced immune thrombocytopenia.
Matzdorff AC. Matzdorff AC. N Engl J Med. 2007 Nov 1;357(18):1870; author reply 1871. N Engl J Med. 2007. PMID: 17985436 No abstract available.
88 results